Effect of aminoguanidine on plasma nitric oxide by-products and blood flow during chronic peritoneal sepsis

被引:27
作者
Alden, KJ
Motew, SJ
Sharma, AC
Ferguson, JL
机构
[1] Univ Illinois, Dept Physiol & Biophys MC 901, Coll Med, Chicago, IL 60612 USA
[2] Univ Illinois, Coll Med, Dept Surg, Chicago, IL 60612 USA
来源
SHOCK | 1998年 / 9卷 / 04期
关键词
D O I
10.1097/00024382-199804000-00009
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
We hypothesized that plasma nitric oxide (NO), generated via inducible NO synthase (iNOS) or endothelial constitutive NO synthase and measured via its by-products NO2- and NO3- (NO2- + NO3- = NOx) would increase and remain elevated during chronic peritoneal sepsis. We further hypothesized that treatment with aminoguanidine (AG; 50 mg/kg), a selective iNOS inhibitor, would decrease NO production and alter blood flow. Sprague Dawley rats were randomized to septic and nonseptic groups. Septic rats received an intraperitoneal cecal slurry (200 mg of cecal material/5 mt 5% dextrose-H2O/kg); control rats received sterile 5% dextrose-H2O (5 mL/kg) only. Plasma NOx and hemodynamics were measured 0, 4, 12, 24, and 48 h after sepsis or sham induction. We also examined the effect of AG, an iNOS inhibitor, on plasma NOx levels and tissue blood flow at 24 h. Septic rats uniformly displayed signs of sepsis, including lethargy, piloerection, and diarrhea. NOx levels were significantly elevated compared with controls at 4, 12, 24, and 48 h (p less than or equal to.05). Septic rats also demonstrated hypotension (t = 12, 24, and 48 h) and tachycardia (t = 4, 12, 24, and 48 h). The infusion of AG (50 mg/kg intravenously for 30 min) at 24 h significantly decreased plasma NOx in septic animals. Plasma NOx concentrations returned to basal levels by 90 min after infusion of AG. In addition, blood flow studies demonstrated that AG treatment in nonseptic rats resulted in a significant decrease in blood flow to the stomach, skin, and adipose tissue, whereas AG infusion did not significantly alter the regional perfusion profile in septic animals. Furthermore, treatment with AG did not significantly alter mean arterial pressure in either group; however, nonseptic animals exhibited a decrease in stroke volume, and septic animals demonstrated an increase in heart rate. In contrast to the rise and fall of NOx levels in endotoxemia, this study demonstrates that the initial rise is sustained during 48 h of peritoneal sepsis. This sustained increase in NOx levels in this model correlated with the observable signs of systemic infection and may relate to enhanced iNOS activity. AG infusion demonstrated variable effects on regional tissue blood flow profiles in septic and nonseptic animals and attenuated the increase in plasma NOx levels in septic animals, an index of iNOS activity.
引用
收藏
页码:289 / 295
页数:7
相关论文
共 46 条
[1]   A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: Comparison with two nonselective strategies [J].
Aranow, JS ;
Zhuang, J ;
Wang, HL ;
Larkin, V ;
Smith, M ;
Fink, MP .
SHOCK, 1996, 5 (02) :116-121
[2]   ABNORMAL CONTRACTILE FUNCTION DUE TO INDUCTION OF NITRIC-OXIDE SYNTHESIS IN RAT CARDIAC MYOCYTES FOLLOWS EXPOSURE TO ACTIVATED MACROPHAGE-CONDITIONED MEDIUM [J].
BALLIGAND, JL ;
UNGUREANU, D ;
KELLY, RA ;
KOBZIK, L ;
PIMENTAL, D ;
MICHEL, T ;
SMITH, TW .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (05) :2314-2319
[3]   THE PATHOGENESIS OF SEPSIS [J].
BONE, RC .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) :457-469
[4]   S-ETHYLISOTHIOUREA, A NONAMINO ACID INHIBITOR OF NITRIC-OXIDE SYNTHASE, REVERSES SEPTIC VASODILATION IN SHEEP [J].
BOOKE, M ;
HINDER, F ;
TRABER, LD ;
MCGUIRE, R ;
TRABER, DL .
SHOCK, 1995, 4 (04) :274-281
[5]   Nitric oxide synthase inhibition versus norepinephrine in ovine sepsis: Effects on regional blood flow [J].
Booke, M ;
Hinder, F ;
McGuire, R ;
Traber, LD ;
Traber, DL .
SHOCK, 1996, 5 (05) :362-370
[6]   NITRIC-OXIDE SYNTHASE PROTEIN AND MESSENGER-RNA ARE DISCRETELY LOCALIZED IN NEURONAL POPULATIONS OF THE MAMMALIAN CNS TOGETHER WITH NADPH DIAPHORASE [J].
BREDT, DS ;
GLATT, CE ;
HWANG, PM ;
FOTUHI, M ;
DAWSON, TM ;
SNYDER, SH .
NEURON, 1991, 7 (04) :615-624
[7]   NITRIC-OXIDE AND CARDIOVASCULAR CONTROL [J].
CALVER, A ;
COLLIER, J ;
VALLANCE, P .
EXPERIMENTAL PHYSIOLOGY, 1993, 78 (03) :303-326
[8]   CALMODULIN IS A SUBUNIT OF NITRIC-OXIDE SYNTHASE FROM MACROPHAGES [J].
CHO, HJ ;
XIE, QW ;
CALAYCAY, J ;
MUMFORD, RA ;
SWIDEREK, KM ;
LEE, TD ;
NATHAN, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (02) :599-604
[9]   N(OMEGA)-AMINO-L-ARGININE, AN INHIBITOR OF NITRIC-OXIDE SYNTHASE, RAISES VASCULAR-RESISTANCE BUT INCREASES MORTALITY-RATES IN AWAKE CANINES CHALLENGED WITH ENDOTOXIN [J].
COBB, JP ;
NATANSON, C ;
HOFFMAN, WD ;
LODATO, RF ;
BANKS, S ;
KOEV, CA ;
SOLOMON, MA ;
ELIN, RJ ;
HOSSEINI, JM ;
DANNER, RL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1175-1182
[10]   AMINOGUANIDINE, A NOVEL INHIBITOR OF NITRIC-OXIDE FORMATION, PREVENTS DIABETIC VASCULAR DYSFUNCTION [J].
CORBETT, JA ;
TILTON, RG ;
CHANG, K ;
HASAN, KS ;
IDO, Y ;
WANG, JL ;
SWEETLAND, MA ;
LANCASTER, JR ;
WILLIAMSON, JR ;
MCDANIEL, ML .
DIABETES, 1992, 41 (04) :552-556